Corcept Therapeutics
CORT
#2078
Rank
$9.07 B
Marketcap
$86.10
Share price
1.71%
Change (1 day)
41.67%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2025 (TTM): $65.57 Million USD

According to Corcept Therapeutics 's latest financial reports the company's current earnings are $0.74 Billion USD. In 2024 the company made an earning of $0.13 Billion USD, an increase over its 2023 earnings that were of $0.10 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $65.57 M-52.12%
2024 $0.13 B27.66%
2023 $0.10 B-4.75%
2022 $0.11 B-9.51%
2021 $0.12 B-2.91%
2020 $0.12 B14.87%
2019 $0.11 B24.71%
2018 $89.49 M69.32%
2017 $52.85 M419.26%
2016 $10.17 M-395.64%
2015 -$3.45 Million-87.53%
2014 -$27.62 Million-33.44%
2013 -$41.5 Million
2011 -$32.34 Million17.84%
2010 -$27.44 Million35.5%
2009 -$20.25 Million2.84%
2008 -$19.69 Million60.81%
2007 -$12.25 Million-52.14%
2006 -$25.59 Million20.91%
2005 -$21.16 Million31.87%
2004 -$16.05 Million60.54%
2003 -$10 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$32.39 B 49,305.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$8.03 B 12,150.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$16.41 B 24,939.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
$22.50 B 34,218.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$11.85 B 17,974.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$23.09 B 35,113.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-$27.45 Million-141.85%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
$30.78 M-53.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.67 B 935.92%๐Ÿ‡บ๐Ÿ‡ธ USA